Urara Shigemi
Nagoya, 4600001, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations.
Journal: Scientific reports
Published: April 12, 2024
Nanopore Sequencing for Characterization of HIV-1 Recombinant Forms.
Journal: Microbiology spectrum
Published: July 27, 2022
Evaluation of the Geenius HIV 1/2 confirmatory assay for HIV-2 samples isolated in Japan.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: February 03, 2022
Specific mutations in the HIV-1 G-tract of the 3'-polypurine tract cause resistance to integrase strand transfer inhibitors.
Journal: The Journal of antimicrobial chemotherapy
Published: August 03, 2021
Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring.
Journal: The Journal of antimicrobial chemotherapy
Published: March 18, 2019
Impact of HIV-1 Integrase L74F and V75I Mutations in a Clinical Isolate on Resistance to Second-Generation Integrase Strand Transfer Inhibitors.
Journal: Antimicrobial agents and chemotherapy
Published: February 14, 2017
HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan.
Journal: AIDS research and human retroviruses
Published: November 17, 2015
A Novel Drug-Resistant HIV-1 Circulating Recombinant Form CRF76_01B Identified by Near Full-Length Genome Analysis.
Journal: AIDS research and human retroviruses
Published: November 04, 2015
Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance.
Journal: Antiviral research
Published: February 18, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026